With the advancement in drug delivery system (DDS) development, CD Bioparticles have achieved significant research results in the field of peptide-dependent drug delivery systems. We can provide you with a variety of services related to peptide-based drug delivery systems to meet your research needs and pilot phase.
Peptides are easy to synthesize, easy to metabolize, have low immunogenicity, and have low toxicity and side effects, which can effectively improve the effect of drugs and reduce the dosage and toxicity of drugs in drug delivery systems.
Peptides can be used as targeting and penetrating peptides to help drugs reach the lesion site more precisely, improve therapeutic effects and reduce side effects.
Peptides can be designed as responsive peptides to achieve response to environmental changes (e.g. pH changes, enzyme activity and redox properties, etc.), thereby releasing drugs under specific conditions and improving the precision and efficiency of drug delivery.
Peptides are capable of self-assembling to form nanostructures, which significantly enhance the stability of peptide drug delivery systems and allows for long-lasting release.
Peptides as building blocks for nanodrugs have the properties of good biocompatibility, self-assembly and chemical variability, which provide a new direction for the construction of smart nano-delivery systems.
Peptide drug conjugates (PDCs) as prodrugs can improve the bioavailability of difficult-to-solve drugs, enhance the selectivity of chemotherapeutic drugs, prolong the duration of drug action, etc., and significantly improve the physicochemical and biopharmacological properties of drugs.
Synthetic peptides, as biocompatible and biodegradable macromolecules, can vary in composition and structure over a wide range, providing diverse options for drug delivery.
Catalog | Products | Structure |
---|---|---|
CDCCP23-001L | 740 Y-P | RQIKIWFQNRRMKWKKSDGG-{Tyr(PO2)}-MDMS |
CDCCP23-008L | iRGD Peptide | CRGDKGPDC (Disulfide bridge:Cys1-Cys9) |
CDCCP23-028L | iRGD Peptide 1 TFA | CRGDKGPDC (TFA sult) |
CDCCP23-031L | PBP10 TFA | RhB-QRLFQVKGRR-OH |
CDCCP23-036L | RGD | RGD |
CDCCP23-041L | TAT (48-57) | GRKKRRQRRR |
CDCCP23-046L | (Arg)9 Acetate | RRRRRRRRR |
CDCCP23-059L | (Arg)9, FAM-labeled | FAM-RRRRRRRRR |
CDCCP23-060L | Biotin-TAT (47-57) | {Biotin}-YGRKKRRQRRR |
CDCCP23-065L | HXR9 | WYPWMKKHHRRRRRRRRR |
CDCCP23-076L | Antennapedia Leader Peptide (CT) | KKWKMRRNQFWVKVQRG |
CDCCP23-090L | TfR-T12 | THRPPMWSPVWP |
CDCCP23-103L | Activable Cell-Penetrating Peptide (ACCP) | DGGDGGDGGDGPLGLAG-{d-Arg}-C |
CDCCP23-113L | SynB1 | RGGRLSYSRRRFSTSTGRA |
References
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.